Alterity Therapeutics (NasdaqCM:ATHE) Conference Transcript

Alterity Therapeutics (NasdaqCM:ATHE) Conference March 24, 2026 10:00 PM ET Company ParticipantsDavid Stamler - CEO and Managing DirectorDavid StamlerGreat. Thank you, Melissa, and hello to everyone. Thank you for joining the presentation. I'm really excited to introduce you to Alterity. If you haven't heard of us before, we've got an exciting development program that is really gonna meet an important unmet need in treating this terrible disease. These are our forward-looking statements. As Melissa mentione ...